CCR5 antagonists have different conformational requirements for the transition to the most thermodynamically stable CCR5 receptor: antagonist complex.

被引：0

作者：

Swinney, DC ^{[1
]}

Beavis, P ^{[1
]}

Kondru, RK ^{[1
]}

Dioszegi, ME ^{[1
]}

Gee, P ^{[1
]}

Zhang, J ^{[1
]}

Sankuratri, S ^{[1
]}

Mirzadegan, T ^{[1
]}

机构：

[1] Roche Palo Alto, Palo Alto, CA 94304 USA

来源：

FASEB JOURNAL | 2006年 / 20卷 / 05期

关键词：

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：A918 / A919

页数：2

共 50 条

[21] Secondary effects of treatment with maraviroc and other CCR5 antagonists. Potential impact of the CCR5 blocker [J].

Arribas Lopez, Jose R. .

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2008, 26 :23-27

[22] Transgenic mouse expressing human CCR5 as a model for in vivo assessments of human selective CCR5 antagonists [J].

Saita, Y ;

Kondo, M ;

Miyazaki, T ;

Yamaji, N ;

Shimizu, Y .

EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 518 (2-3) :227-233

[23] Binding of fusion protein FLSC IgG1 to CCR5 is enhanced by CCR5 antagonist Maraviroc [J].

Latinovic, Olga ;

Szmacinski, Henryk ;

Schneider, Kate ;

Lakowicz, Joseph ;

Heredia, Alonso ;

Redfield, Robert .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2014, 67 :82-82

[24] Treatment with CCR5 antagonists: Which patient may have a benefit? [J].

Mueller, M. C. ;

Bogner, J. R. .

EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2007, 12 (09) :441-452

[25] Binding of fusion protein FLSC IgG1 to CCR5 is enhanced by CCR5 antagonist Maraviroc [J].

Latinovic, Olga ;

Schneider, Kate ;

Szmacinski, Henryk ;

Lakowicz, Joseph R. ;

Heredia, Alonso ;

Redfield, Robert R. .

ANTIVIRAL RESEARCH, 2014, 112 :80-90

[26] Comparative Docking Study of Anibamine as the First Natural Product CCR5 Antagonist in CCR5 Homology Models [J].

Li, Guo ;

Haney, Kendra M. ;

Kellogg, Glen E. ;

Zhang, Yan .

JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2009, 49 (01) :120-132

[27] Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5 [J].

Ogilvie, P ;

Bardi, G ;

Clark-Lewis, I ;

Baggiolini, M ;

Uguccioni, M .

BLOOD, 2001, 97 (07) :1920-1924

[28] Chemokine CCR5 and cocaine interactions in the brain: Cocaine enhances mesolimbic CCR5 mRNA levels and produces place preference and locomotor activation that are reduced by a CCR5 antagonist [J].

Nayak, Sunil U. ;

Cicalese, Stephanie ;

Tallarida, Chris ;

Oliver, Chicora F. ;

Rawls, Scott M. .

BRAIN BEHAVIOR AND IMMUNITY, 2020, 83 :288-292

[29] Docking and CoMFA study on novel human CCR5 receptor antagonists [J].

Jahan B. Ghasemi ;

Maryam Nouri .

Medicinal Chemistry Research, 2013, 22 :1356-1364

[30] CCR5 antagonists in the treatment of treatment-experienced patients infected with CCR5 tropic HIV-1 [J].

Lorenzen, Thore ;

Stoehr, Albrecht ;

Walther, Irene ;

Plettenberg, Andreas .

EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2007, 12 (09) :419-425

← 1 2 3 4 5 →